Stage-specific treatment of colorectal cancer: A microRNA-nanocomposite approach

Colorectal cancer (CRC) is among the leading causes of cancer mortality. The lifetime risk of developing CRC is about 5% in adult males and females. CRC is usually diagnosed at an advanced stage, and at this point therapy has a limited impact on cure rates and long-term survival. Novel and/or improv...

Full description

Bibliographic Details
Published in:Journal of Pharmaceutical Analysis
Main Authors: Adewale Oluwaseun Fadaka, Taiwo Akinsoji, Ashwil Klein, Abram Madimabe Madiehe, Mervin Meyer, Marshall Keyster, Lucky Mashudu Sikhwivhilu, Nicole Remaliah Samantha Sibuyi
Format: Article
Language:English
Published: Elsevier 2023-11-01
Subjects:
Colorectal cancer
microRNA
Nanotechnology
Nanocarriers
OncomiRs
TSmiRs
Online Access:http://www.sciencedirect.com/science/article/pii/S2095177923001478

Internet

http://www.sciencedirect.com/science/article/pii/S2095177923001478

Similar Items